Recap of Stellar Biotechnologies Inc. (SBOTF) and its Accomplishments This Past Year
Since becoming a leader of Keyhole Limpet Hemocyanin (KLH) production, Stellar Biotechnologies Inc. (OTCQB: SBOTF) continues its objectives towards commercial expansion of its product with immunotherapy treatments. KLH is an immune stimulating protein that aids in fighting immune deficient illnesses like cancer, Alzheimer’s Disease, and many inflammatory diseases. The company has successfully maintained its partnerships with various companies to meet its goals. Since 2013, Stellar and Amaran Biotechnologies Inc. have collaborated on manufacturing the OBI-822 immunotherapy that uses KLH as an important immune stimulator. The companies have completed all of their initial objectives and will now focus on commercial manufacturing…